Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

24.01.2019 | review | Ausgabe 1/2019 Open Access

memo - Magazine of European Medical Oncology 1/2019

ESMO 2018—personal highlights

memo - Magazine of European Medical Oncology > Ausgabe 1/2019
Isabel Heidegger, Wolfgang Hilbe, Andreas Pircher
Wichtige Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


This article intends to summarize personal highlights of the ESMO (European Society for Medical Oncology) 2018 meeting and does not aim to give a comprehensive overview. We will summarize the most recent presented data on the treatment of non-small cell lung establishing first-line combinational therapies (chemotherapy backbone with immunotherapy) as standard of care. Furthermore highly practice relevant data on the treatment of recurrent or metastatic head and neck squamous cell carcinoma were presented. Next the treatment landscape of metastatic prostate cancer is changing rapidly and some new aspects in metastatic disease are reported.

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 1/2019

memo - Magazine of European Medical Oncology 1/2019 Zur Ausgabe